Antibiotic combinations: should they be tested?

Por Eliopoulos, G M, Eliopoulos, C T
Publicado em 1988

Antimicrobial Activity of Quinupristin-Dalfopristin Combined with Other Antibiotics against Vancomycin-Resistant Enterococci

Por Eliopoulos, G. M., Wennersten, C. B.
Publicado em 2002

Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

Por Eliopoulos, G M, Moellering, R C
Publicado em 1981

Resistance to beta-lactam antibiotics in Streptococcus faecium.

Por Eliopoulos, G M, Wennersten, C, Moellering, R C
Publicado em 1982

In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.

Por Eliopoulos, G M, Reiszner, E, Moellering, R C
Publicado em 1985

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Por Eliopoulos, G M, Gardella, A, Moellering, R C
Publicado em 1984

Antimicrobial susceptibilities of a Corynebacterium CDC group I1 strain isolated from a patient with endocarditis.

Por Malanoski, G J, Parker, R, Eliopoulos, G M
Publicado em 1992

In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.

Por Rice, L B, Eliopoulos, G M, Moellering, R C
Publicado em 1989

Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound.

Por Daly, J S, Eliopoulos, G M, Willey, S, Moellering, R C
Publicado em 1988

In vitro activity of SK&F 104662, a new glycopeptide antibiotic.

Por Yao, J D, Eliopoulos, G M, Moellering, R C
Publicado em 1989

Activities of the Oxazolidinones Linezolid and Eperezolid in Experimental Intra-Abdominal Abscess Due to Enterococcus faecalis or Vancomycin-Resistant Enterococcus faecium

Por Schülin, T., Thauvin-Eliopoulos, C., Moellering, R. C., Eliopoulos, G. M.
Publicado em 1999

In Vitro Activity of the New Oxazolidinone AZD2563 against Enterococci

Por Eliopoulos, G. M., Wennersten, C. B., Moellering Jr., R. C.
Publicado em 2002

In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.

Por Schülin, T, Wennersten, C B, Moellering, R C, Eliopoulos, G M
Publicado em 1997

In vitro activity of BAY v 3522, a new cephalosporin for oral administration.

Por Hodges, T L, Eliopoulos, G M, Klimm, K, Moellering, R C
Publicado em 1990

In vitro activity of BMY-28100, a new oral cephalosporin.

Por Eliopoulos, G M, Reiszner, E, Wennersten, C, Moellering, R C
Publicado em 1987

Comparative in vitro activity of CGP 31608, a new penem antibiotic.

Por Eliopoulos, G M, Wennersten, C, Reiszner, E, Moellering, R C
Publicado em 1987

In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.

Por Eliopoulos, G M, Thauvin, C, Gerson, B, Moellering, R C
Publicado em 1985

Antagonistic effect of penicillin-amikacin combinations against enterococci.

Por Thauvin, C, Eliopoulos, G M, Wennersten, C, Moellering, R C
Publicado em 1985

In vitro activities in new oxazolidinone antimicrobial agents against enterococci.

Por Eliopoulos, G M, Wennersten, C B, Gold, H S, Moellering, R C
Publicado em 1996

In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.

Por Eliopoulos, G M, Moellering, A E, Reiszner, E, Moellering, R C
Publicado em 1985